HOUSTON--(BUSINESS WIRE)--Dr. Ira L. Goldknopf, the Director of Proteomics for Power3 Medical Products Inc. (OTC: PWRM, www.Power3Medical.com), will participate in the third annual CNS Diseases Congress at the Hilton Boston Back Bay, June 25-26, speaking on his company’s progress in proteomic blood-based testing for early diagnosis of Alzheimer’s disease. The Congress (www.srinstitute.com) features presentations from leading industry and academic researchers from around the world who have made important contributions to the advancement of new treatments for CNS (central nervous system) diseases.
